Clinical Trials Logo

Amaurosis Fugax clinical trials

View clinical trials related to Amaurosis Fugax.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT03753893 Completed - Macular Edema Clinical Trials

Ocular Manifestations in Rheumatic Diseases

Start date: May 1, 2013
Phase:
Study type: Observational

This is a search strategy for determining the prevalence of ocular complications in inflammatory rheumatic diseases for the purposes of a meta analysis.

NCT ID: NCT01645306 Completed - Stroke Clinical Trials

Revacept in Symptomatic Carotid Stenosis

RevaceptCS02
Start date: March 8, 2013
Phase: Phase 2
Study type: Interventional

Patients suffering from symptomatic carotid artery stenosis, transient ischemic attacks (TIAs), amaurosis fugax or stroke receive either Revacept (single dose) plus antiplatelet monotherapy or monotherapy alone. Patients receive a single dose of trial medication by intravenous infusion for 20 minutes. Patients are followed up one and three days after treatment, at 3 months and by a telephone interview at 12 months.